Professional Summary
Practice Locations
Referring Physicians
Biography
Dr. Lawrence Fung is an associate professor at the Department of Psychiatry and Behavioral Sciences at Stanford University. He is the director of the Stanford Neurodiversity Project, director of the Neurodiversity Clinic, and principal investigator at the Fung Lab. His work, which focuses on autism and neurodiversity, traverses from multi-modal neuroimaging studies to a new conceptualization of neurodiversity and its application to clinical, educational, and employment settings. His lab advances the understanding of neural bases of human socio-communicative and cognitive functions by using novel neuroimaging and bioanalytical technologies. Using a community-based participatory research approach, his team devises and implements novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. His work has been supported by various agencies, including the National Institutes of Health, Autism Speaks, California Department of Developmental Services, California Department of Rehabilitation, and philanthropy. He received his Ph.D. in chemical engineering from Cornell University and his M.D. from George Washington University. He completed his general psychiatry residency, child and adolescent psychiatry fellowship, and postdoctoral research fellowship at Stanford.
View Full Biography
Professional Summary
Education & Certifications
- Fellowship: Stanford University Child and Adolescent Psychiatry Fellowship (2014) CA
- Residency: Stanford University Psychiatry and Behavioral Sciences (2012) CA
- Internship: Stanford University Psychiatry and Behavioral Sciences (2010) CA
- Board Certification, American Board of Psychiatry and Neurology, Child and Adolescent Psychiatry (2015)
- Fellowship, Stanford University Medical Center, Child and Adolescent Psychiatry (2014)
- Board Certification, American Board of Psychiatry and Neurology, Psychiatry (2013)
- Residency, Stanford University Medical Center, General Psychiatry (2013)
- Internship, Stanford University, Psychiatry (2010)
- MD, George Washington University, Medicine (2009)
- PhD, Cornell University, Chemical Engineering (1998)
- MSE, Johns Hopkins University, Chemical Engineering (1996)
- B.S. (Honors), University of California at Berkeley, Chemical Engineering (1993)
Honors & Awards
- AACAP Pilot Research Award, American Academy of Child & Adolescent Psychiatry (2013-2014)
- ACNP Travel Award, American College of Neuropsychopharmacology (2015)
- Brain Camp III participant, National Institute of Mental Health (2011)
- Chairman’s Award on Community Commitment and Engagement, Department of Psychiatry and Behavioral Sciences, Stanford University (2020)
- Clinical Investigator Award / Mentored Clinical Scientist Research Career Development Award (K08), National Institute of Mental Health (2016-2020)
- Faculty Professional & Leadership Development Award, Department of Psychiatry and Behavioral Sciences, Stanford University (2020)
- Finalist, National Institutes of Health Director’s Early Independence Award (DP5), National Institutes of Health (2013)
- Janssen Resident Psychiatric Research Scholar, American Psychiatric Institute on Research and Education (2010)
- Miller Award, Department of Psychiatry & Behavioral Sciences, Stanford University (2012)
- NIMH Outstanding Resident Award, National Institute of Mental Health (2011)
- Nominee, Career Awards for Medical Scientists (selected from Stanford Univ-wide search), Burroughs Wellcome Fund (2013)
- Nominee, NIH Director’s Early Independence Award (DP5) (selected from Stanford Univ-wide search), National Institutes of Health (2012)
- Outstanding General Psychiatry Resident Award, American Academy of Child & Adolescent Psychiatry (2010)
- Runner-up in Resident Poster Competition, Session 2, APA Annual Meeting, American Psychiatric Association (2013)
- Ruth L. Kirschstein Individual Postdoctoral National Research Service Award, National Institute of Mental Health (2013-2014)
- Scholar, Career Development Institute for Psychiatry (2013)
- SOBP Travel Fellowship Award, Society of Biological Psychiatry (2017)
- Trainee Travel Award, Academy of Psychosomatic Medicine (2011)
- Young Investigator Award, International Symposium on Functional NeuroReceptor Mapping of the Living Brain (2016)
Memberships
- Distinguished Fellow, American Academy of Child and Adolescent Psychiatry (2024 - Present)
- Associate Editor, Research in Autism Spectrum Disorders (2023 - Present)
- Associate Editor, Journal of Autism and Developmental Disorders (2022 - Present)
- Associate Editor, Frontiers in Psychiatry (2022 - Present)
- Member, Board of Directors, Helping Adults with Autism Perform & Excel (2021 - Present)
- President, Bay Area Autism Consortium (2021 - Present)
- Fellow, American Psychiatric Association (2019 - Present)
- Member, Board of Directors, Autism Asperger’s Spectrum Coalition for Education, Networking and Development (2019 - Present)
- Member, Board of Directors, Bay Area Autism Consortium (2019 - Present)
- Associate Member, American College of Neuropsychopharmacology (2018 - Present)
- Member, Society of Biological Psychiatry (2012 - Present)
- Member, International Society for Autism Research (2009 - Present)
- Member, American Academy of Child & Adolescent Psychiatry (2008 - Present)
- Member, American Psychiatric Association (2008 - 2019)
Administrative Appointments
- Attending physician, Pediatric Neuropsychopharmacology Clinic (2015 - 2018)
- Attending physician, Autism & Developmental Disabilities Clinic (2015 - Present)
- Director, Neurodiversity Clinic (2018 - Present)
- Director, Stanford Neurodiversity Project (2018 - Present)
- Director of Dissemination and Outreach Core, Center for Sleep in Autism, Stanford University (2022 - 2027)
Publications
-
Polymeric implants for cancer chemotherapy.
Saltzman, W. M., & Fung, L. K. (1997). Polymeric implants for cancer chemotherapy. Advanced Drug Delivery Reviews, 26(2-3), 209–230. -
Shift in pH of biological fluids during storage and processing: effect on bioanalysis
Fura, A., Harper, T. W., Zhang, H. J., Fung, L., & Shyu, W. C. (2003). Shift in pH of biological fluids during storage and processing: effect on bioanalysis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 32(3), 513–522. -
2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: Synthesis, binding studies and behavioral efficacy
Dubowchik, G. M., Michne, J. A., Zuev, D., Schwartz, W., Scola, P. M., James, C. A., … Zhang, J. (2003). 2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: Synthesis, binding studies and behavioral efficacy. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 13(22), 3997–4000. -
Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists
Han, X. J., Pin, S. S., Burris, K., Fung, L. K., Huang, S., Taber, M. T., … Dubowchik, G. M. (2005). Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 15(18), 4029–4032. -
Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists
Han, X. J., Michne, J. A., Pin, S. S., Burris, K. D., Balanda, L. A., Fung, L. K., … Dubowchik, G. M. (2005). Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 15(17), 3870–3873. -
Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution
Blum, C. A., Zheng, X., Brielmann, H., Hodgetts, K. J., Bakthavatchalam, R., Chandrasekhar, J., … Chenard, B. L. (2008). Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 18(16), 4573–4577. -
Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children
Mattai, A., Fung, L., Bakalar, J., Overman, G., Tossell, J., Miller, R., … Gogtay, N. (2009). Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 24(7), 584–589. -
Risperidone: Switching from Brand Name to Generic
Hardan, A. Y., Fung, L. K., & Amin, H. (2010). Risperidone: Switching from Brand Name to Generic. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 20(5), 457–458. -
Discovery of N-(1-Ethylpropyl)-(3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl)amine 59 (NGD 98-2): An Orally Active Corticotropin Releasing Factor-1 (CRF-1) Receptor Antagonist
Hodgetts, K. J., Ge, P., Yoon, T., De Lombaert, S., Brodbeck, R., Gulianello, M., … Doller, D. (2011). Discovery of N-(1-Ethylpropyl)-(3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl)amine 59 (NGD 98-2): An Orally Active Corticotropin Releasing Factor-1 (CRF-1) Receptor Antagonist. JOURNAL OF MEDICINAL CHEMISTRY, 54(12), 4187–4206. -
A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism
Hardan, A. Y., Fung, L. K., Libove, R. A., Obukhanych, T. V., Nair, S., Herzenberg, L. A., … Tirouvanziam, R. (2012). A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism. BIOLOGICAL PSYCHIATRY, 71(11), 956–61. -
Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome
Fung, L. K., Quintin, E.-M., Haas, B. W., & Reiss, A. L. (2012). Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome. CURRENT OPINION IN NEUROLOGY, 25(2), 112–24. -
A Retrospective Review of the Effectiveness of Aripiprazole in the Treatment of Sensory Abnormalities in Autism
Fung, L. K., Chahal, L., Libove, R. A., Bivas, R., & Hardan, A. Y. (2012). A Retrospective Review of the Effectiveness of Aripiprazole in the Treatment of Sensory Abnormalities in Autism. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 22(3), 245–48. -
Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants
Strasser, J. F., Fung, L. K., Eller, S., Grossman, S. A., & Saltzman, W. M. (1995). Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 275(3), 1647–1655. -
Distribution of drugs following controlled delivery to the brain interstitium
Mak, M., Fung, L., Strasser, J. F., & Saltzman, W. M. (1995). Distribution of drugs following controlled delivery to the brain interstitium. JOURNAL OF NEURO-ONCOLOGY, 26(2), 91–102. -
Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain
Fung, L. K., Shin, M., Tyler, B., Brem, H., & Saltzman, W. M. (1996). Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. PHARMACEUTICAL RESEARCH, 13(5), 671–682. -
Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain
Fung, L. K., Ewend, M. G., Sills, A., Sipos, E. P., Thompson, R., Watts, M., … Saltzman, W. M. (1998). Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. CANCER RESEARCH, 58(4), 672–684. -
Autism spectrum and neurodevelopmental disorders: clinical update for psychiatrists
Froehlich, W., & Fung, L. K. (2012). Autism spectrum and neurodevelopmental disorders: clinical update for psychiatrists. PSYCHIATRIC TIMES, 29(11). -
Attitudes toward neuroscience education among psychiatry residents and fellows.
Fung, L. K., Akil, M., Widge, A., Roberts, L. W., & Etkin, A. (2014). Attitudes toward neuroscience education among psychiatry residents and fellows. Academic Psychiatry , 38(2), 127–34. -
Brief Report: An Open-Label Study of the Neurosteroid Pregnenolone in Adults with Autism Spectrum Disorder
Fung, L. K., Libove, R. A., Phillips, J., Haddad, F., & Hardan, A. Y. (2014). Brief Report: An Open-Label Study of the Neurosteroid Pregnenolone in Adults with Autism Spectrum Disorder. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 44(11), 2971–77. -
Autism in DSM-5 under the microscope: Implications to patients, families, clinicians, and researchers.
Fung, L. K., & Hardan, A. Y. (2014). Autism in DSM-5 under the microscope: Implications to patients, families, clinicians, and researchers. Asian Journal of Psychiatry, 11, 93–97. -
Attitudes Toward Neuroscience Education in Psychiatry: a National Multi-stakeholder Survey
Fung, L. K., Akil, M., Widge, A., Roberts, L. W., & Etkin, A. (2015). Attitudes Toward Neuroscience Education in Psychiatry: a National Multi-stakeholder Survey. ACADEMIC PSYCHIATRY, 39(2), 139–46. -
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date
Fung, L. K., & Hardan, A. Y. (2015). Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date. CNS DRUGS, 29(6), 453–63. -
A proton spectroscopy study of white matter in children with autism.
Hardan, A. Y., Fung, L. K., Frazier, T., Berquist, S. W., Minshew, N. J., Keshavan, M. S., & Stanley, J. A. (2016). A proton spectroscopy study of white matter in children with autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 66, 48–53. -
Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome
Fung, L. K., & Reiss, A. L. (2016). Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome. BIOLOGICAL PSYCHIATRY, 80(2), 100–111. -
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., … Hardan, A. Y. (2016). Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis. Pediatrics, 137, S124–35. -
Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care
McGuire, K., Fung, L. K., Hagopian, L., Vasa, R. A., Mahajan, R., Bernal, P., … Whitaker, A. H. (2016). Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care. PEDIATRICS, 137, S136–S148. -
Effects of common anesthetic agents on [F-18] flumazenil binding to the GABA(A) receptor
Palner, M., Beinat, C., Banister, S., Zanderigo, F., Park, J. H., Shen, B., … Chin, F. T. (2016). Effects of common anesthetic agents on [F-18] flumazenil binding to the GABA(A) receptor. EJNMMI RESEARCH, 6. -
A sterile animal model for neuroinflammation?
Fung, L. K. (2017). A sterile animal model for neuroinflammation? Science Translational Medicine, 9(373). -
Imaging serotonin reuptake in the living brain.
Fung, L. K. (2016). Imaging serotonin reuptake in the living brain. Science Translational Medicine, 8(367), 367ec191-? -
Comprehensive Examination of the GABAergic System in Adults With Autism by Simultaneous [18F] Flumazenil-Positron Emission Tomography and Magnetic Resonance Spectroscopy
Fung, L., Flores, R., Liu, K., Gu, M., Spielman, D., Chin, F., & Hardan, A. (2017). Comprehensive Examination of the GABAergic System in Adults With Autism by Simultaneous [18F] Flumazenil-Positron Emission Tomography and Magnetic Resonance Spectroscopy. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP. -
THE FRAGILE X BRAIN: A PET/MR CASE STUDY
Gade, S., Gade, S., Shen, B., Jung, J. H., Lee, B. C., Kim, S. E., … Chin, F. (2018). THE FRAGILE X BRAIN: A PET/MR CASE STUDY. ANNALS OF BEHAVIORAL MEDICINE, 52, S713. -
Studying GABA Neurophysiology by Simultaneous [18F]Flumazenil-Positron Emission Tomography and Magnetic Resonance Spectroscopy
Fung, L., Gu, M., Leuze, C., Hjoernevik, T., Shen, B., Park, J. H., … Chin, F. (2016). Studying GABA Neurophysiology by Simultaneous [18F]Flumazenil-Positron Emission Tomography and Magnetic Resonance Spectroscopy. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP. -
Intranasal Vasopressin Treatment Improves Social Abilities in Children With Autism
Parker, K., Oztan, O., Libove, R., Sumiyoshi, R., Summers, J., Hinman, K., … Hardan, A. (2016). Intranasal Vasopressin Treatment Improves Social Abilities in Children With Autism. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP. -
Simultaneous [18F]Flumazenil-Positron Emission Tomography and GABA-Magnetic Resonance Spectroscopy in Adults with Autism and Healthy Volunteers
Fung, L., Flores, R., Gu, M., Hjoernevik, T., Hardan, A., Spielman, D., & Chin, F. (2017). Simultaneous [18F]Flumazenil-Positron Emission Tomography and GABA-Magnetic Resonance Spectroscopy in Adults with Autism and Healthy Volunteers. BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC. -
Pregnenolone in the Treatment of Irritability in Autism Spectrum Disorder: A Post-Hoc Metabolomic Analysis
Fung, L., Sun, W., Libove, R., Tanaka, S., Kwa, L., Philips, J., … Hardan, A. (2015). Pregnenolone in the Treatment of Irritability in Autism Spectrum Disorder: A Post-Hoc Metabolomic Analysis. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP. -
Investigating the Attitudes Toward Neuroscience Education in Psychiatry -- The Stanford Education in Neuroscience Study (SENS)
Fung, L., Akil, M., Widge, A., Roberts, L., & Etkin, A. (2013). Investigating the Attitudes Toward Neuroscience Education in Psychiatry -- The Stanford Education in Neuroscience Study (SENS). BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC. -
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.
Fung, L. K., & Hardan, A. Y. (2015). Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date. CNS Drugs. -
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
Parker, K. J., Oztan, O., Libove, R. A., Mohsin, N., Karhson, D. S., Sumiyoshi, R. D., … Hardan, A. Y. (2019). A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. SCIENCE TRANSLATIONAL MEDICINE, 11(491). -
Brief Report: Sex/Gender Differences in Symptomology and Camouflaging in Adults with Autism Spectrum Disorder
Schuck, R. K., Flores, R. E., & Fung, L. K. (2019). Brief Report: Sex/Gender Differences in Symptomology and Camouflaging in Adults with Autism Spectrum Disorder. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 49(6), 2597–2604. -
Autism and toe-walking: are they related? Trends and treatment patterns between 2005 and 2016
Leyden, J., Fung, L., & Frick, S. (2019). Autism and toe-walking: are they related? Trends and treatment patterns between 2005 and 2016. JOURNAL OF CHILDRENS ORTHOPAEDICS, 13(4), 340–45. -
Thalamic and prefrontal GABA concentrations but not GABAA receptor densities are altered in high-functioning adults with autism spectrum disorder.
Fung, L. K., Flores, R. E., Gu, M., Sun, K. L., James, D., Schuck, R. K., … Hardan, A. Y. (2020). Thalamic and prefrontal GABA concentrations but not GABAA receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular Psychiatry. -
Association of serum allopregnanolone with restricted and repetitive behaviors in adult males with autism.
Chew, L., Sun, K. L., Sun, W., Wang, Z., Rajadas, J., Flores, R. E., … Fung, L. K. (2020). Association of serum allopregnanolone with restricted and repetitive behaviors in adult males with autism. Psychoneuroendocrinology, 123, 105039. -
Neurodevelopmental Disorders
Hong, D. S., Fung, L. K., & Hardan, A. (2019). Neurodevelopmental Disorders. AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING TEXTBOOK OF PSYCHIATRY, 7TH EDITION, 225–55. -
Sex Differences in Resting-State Functional Connectivity in High-Functioning Adults With Autism
Sun, K., Ayub, R., Lam, V., Saggar, M., & Fung, L. (2020). Sex Differences in Resting-State Functional Connectivity in High-Functioning Adults With Autism. NEUROPSYCHOPHARMACOLOGY, 45(SUPPL 1), 297–98. -
Genetic disorders associated with the autism spectrum disorder phenotype
Fung, L. K., & Reiss, A. L. (2016). Genetic disorders associated with the autism spectrum disorder phenotype. Primer on Autism Spectrum Disorder (pp. 117–137). Oxford University Press. -
Corpus Callosum and Autism
Fung, L. K., & Hardan, A. Y. (2017). Corpus Callosum and Autism. Autism Imaging and Devices (pp. 157–169). CRC Press. -
Oxidative Stress in Psychiatric Disorders
Fung, L., & Hardan, A. (2019). Oxidative Stress in Psychiatric Disorders. The Therapeutic use of N-Acetylcysteine (NAC) in Medicine (pp. 53–72). Springer Nature. -
Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults.
Ayub, R., Sun, K. L., Flores, R. E., Lam, V. T., Jo, B., Saggar, M., & Fung, L. K. (2021). Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults. Translational Psychiatry, 11(1), 93. -
Socio-Communicative Deficits are Modulated by GABA Concentrations but Not GABA(A) Receptor Densities in Adults With Autism Spectrum Disorder
Fung, L., Flores, R., Gu, M., Spielman, D., Chin, F., & Hardan, A. (2018). Socio-Communicative Deficits are Modulated by GABA Concentrations but Not GABA(A) Receptor Densities in Adults With Autism Spectrum Disorder. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP. -
Interrogating the GABAergic system with simultaneous [F-18]-Flumazenilpositron emission tomography and GABA-magnetic resonance spectroscopy in healthy volunteers
Fung, L., Flores, R., Gu, M., Leuze, C., Hjoernevik, T., Shen, B., … Chin, F. (2017). Interrogating the GABAergic system with simultaneous [F-18]-Flumazenilpositron emission tomography and GABA-magnetic resonance spectroscopy in healthy volunteers. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. SAGE PUBLICATIONS INC. -
ANXIETY IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER: CLINICAL ASSESSMENT, BIOLOGY, AND TREATMENTS
Hardan, A., Fung, L. K., & King, B. H. (2016). ANXIETY IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER: CLINICAL ASSESSMENT, BIOLOGY, AND TREATMENTS. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. ELSEVIER SCIENCE INC. -
Neurodiversity: From Phenomenology to Neurobiology and Enhancing Technologies
Fung, L. K. (Ed.). (2021). Neurodiversity: From Phenomenology to Neurobiology and Enhancing Technologies. American Psychiatric Publishing Inc. -
Neurodiversity: The New Diversity
Fung, L. K., & Doyle, N. (2021). Neurodiversity: The New Diversity. Neurodiversity: from Phenomenology to Neurobiology and Enhancing Technologies. American Psychiatric Association Publishing. -
Strengths-Based Model of Autism
Fung, L. K. (2021). Strengths-Based Model of Autism. Neurodiversity: from Phenomenology to Neurobiology and Enhancing Technologies. American Psychiatric Association Publishing. -
Strengths-Based Model of Attention Deficit Hyperactivity Disorder
Fung, L. K. (2021). Strengths-Based Model of Attention Deficit Hyperactivity Disorder. Neurodiversity: from Phenomenology to Neurobiology and Enhancing Technologies. American Psychiatric Association Publishing. -
Neurobiology of Neurodiversity
Fung, L. K. (2021). Neurobiology of Neurodiversity. Neurodiversity: from Phenomenology to Neurobiology and Enhancing Technologies. American Psychiatric Association Publishing. -
Region-specific associations between gamma-aminobutyric acid A receptor binding and cortical thickness in high-functioning autistic adults.
James, D., Lam, V. T., Jo, B., & Fung, L. K. (2022). Region-specific associations between gamma-aminobutyric acid A receptor binding and cortical thickness in high-functioning autistic adults. Autism Research : Official Journal of the International Society for Autism Research. -
A Scoping Review of Peer Mentoring Programs for Autistic College Students
Morris, I. F., Matta, C., & Fung, L. K. (2022). A Scoping Review of Peer Mentoring Programs for Autistic College Students. Review Journal of Autism and Developmental Disorders . -
The impact of autism-related training programs on physician knowledge, self-efficacy, and practice behavior: A systematic review.
Clarke, L., & Fung, L. K. (2022). The impact of autism-related training programs on physician knowledge, self-efficacy, and practice behavior: A systematic review. Autism : the International Journal of Research and Practice, 13623613221102016. -
"Self-compassion changed my life": The self-compassion experiences of autistic and non-autistic adults and its relationship with mental health and psychological wellbeing.
Cai, R. Y., Gibbs, V., Love, A., Robinson, A., Fung, L., & Brown, L. (2022). "Self-compassion changed my life": The self-compassion experiences of autistic and non-autistic adults and its relationship with mental health and psychological wellbeing. Journal of Autism and Developmental Disorders. -
Autism and toe-walking: are they related? Trends and treatment patterns between 2005 and 2016.
Leyden, J., Fung, L., & Frick, S. (2019). Autism and toe-walking: are they related? Trends and treatment patterns between 2005 and 2016. Journal of Children's Orthopaedics, 13(4), 340–345. -
Autism Spectrum Disorder
Fung, L. K. (2018). Autism Spectrum Disorder. STUDENT MENTAL HEALTH: A GUIDE FOR PSYCHIATRISTS, PSYCHOLOGISTS, AND LEADERS SERVING IN HIGHER EDUCATION, 299–319. -
CORTISOL IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER: META-ANALYSIS AND SYSTEMATIC REVIEW
Fung, L. K. (2016). CORTISOL IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER: META-ANALYSIS AND SYSTEMATIC REVIEW. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. ELSEVIER SCIENCE INC. -
Use of Lithium Carbonate in the Management of Clozapine-Induced Neutropenia in Childhood-Onset Schizophrenia
Mattai, A., Fung, L., Bakalar, J., Tossell, J., Miller, R., Rapoport, J., & Gogtay, N. (2009). Use of Lithium Carbonate in the Management of Clozapine-Induced Neutropenia in Childhood-Onset Schizophrenia. BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC. -
NEURODIVERSITY: AN INVISIBLE STRENGTH?
Fung, L. K., Ulrich, T. L., Fujimoto, K. T., & Taheri, M. (2022). NEURODIVERSITY: AN INVISIBLE STRENGTH? JOM, 74(9), 3200–3202. -
FAR: End-to-End Vibrotactile Distributed System Designed to Facilitate Affect Regulation in Children Diagnosed with Autism Spectrum Disorder Through Slow Breathing
Miri, P., Arora, M., Malhotra, A., Flory, R., Hu, S., Lowber, A., … Marzullo, K. (2022). FAR: End-to-End Vibrotactile Distributed System Designed to Facilitate Affect Regulation in Children Diagnosed with Autism Spectrum Disorder Through Slow Breathing. PROCEEDINGS OF THE 2022 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI' 22). ASSOC COMPUTING MACHINERY. -
A dual design thinking - universal design approach to catalyze neurodiversity advocacy through collaboration among high-schoolers.
Schuck, R. K., & Fung, L. K. (2023). A dual design thinking - universal design approach to catalyze neurodiversity advocacy through collaboration among high-schoolers. Frontiers in Psychiatry, 14, 1250895. -
Strengths-Based Models and Neurodiversity
Fung, L. K. (2024). Strengths-Based Models and Neurodiversity. Neurodiversity and Work: Employment, Identity, and Support Networks for Neurominorities (pp. 39–59). Springer Nature, Switzerland.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
,
,
Outpatient Psychiatry Clinic ,
,Outpatient Psychiatry Clinic
Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records